Neogen Corporation
Organization details
- Legal name
- Neogen Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Michigan
- Headquarters city
- Lansing
- Headquarters state / province
- Michigan
- Headquarters country
- United States
- Fiscal year end
- May
- Ticker symbol
- NEOG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000711377
- EIN
- 38-2367843
Board of directors
-
Aashima Gupta · DirectorSince 2023
-
Andrea F. Wainer · DirectorSince 2025
-
Avi Pelossof · DirectorSince 2025
-
Catherine E. Woteki · DirectorSince 2023
-
James C. Borel · DirectorSince 2023
-
James P. Tobin · DirectorSince 2023
-
Jeffrey D. Capello · DirectorSince 2023
-
John Edward Adent · Director · President & CEOSince 2023
-
Mikheal Nassif · Director · CEOSince 2025
-
Rafael A. Rodriguez · DirectorSince 2023
-
Ronald D. Green · DirectorSince 2023
-
Thierry Bernard · DirectorSince 2024
-
William T. Boehm · DirectorSince 2023
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 29
-2.7% a year in revenue
20% of the scoring weight is on file. Figures cover May 2025 – May 2026.
Director election results
Annual meeting of October 1, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.3%
-
98.9%
-
99.0%
Board connections
4 of this board's directors also sit on 4 other boards. 1 is in the same sector.
-
Agios Pharmaceuticals Inc. Same sectorvia Jeffrey D. Capello
- via Andrea F. Wainer
- via Thierry Bernard
- via Aashima Gupta
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $12,421
- 6 purchases by 1 insider
- Sold, last 12 months
- $114,676
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Yarwood Jeremy Officer (Chief Scientific Officer) | Open-market sale | −9,051 | $12.67 | $114,676 |
| Nov 3, 2026 | Yarwood Jeremy Officer (Chief Scientific Officer) | Option exercise | +16,207 | $11.82 | $191,567 |
| Nov 3, 2026 | Yarwood Jeremy Officer (Chief Scientific Officer) | Shares withheld for tax | −7,156 | $11.82 | $84,584 |
| Nov 2, 2026 | Freels Joe B Officer (Chief Commercial Officer) | Grant or award | +6,345 | $11.82 | $74,998 |
| Oct 29, 2026 | James C. Borel Director | Option exercise | +1,776 | $12.21 | $21,685 |
| Oct 29, 2026 | Jeffrey D. Capello Director | Option exercise | +1,776 | $12.21 | $21,685 |
| Oct 29, 2026 | Ronald D. Green Director | Option exercise | +1,776 | $12.21 | $21,685 |
| Oct 29, 2026 | Aashima Gupta Director | Option exercise | +1,776 | $12.21 | $21,685 |
| Oct 29, 2026 | Hastings Gregory S Officer (VP, Animal Health) | Option exercise | +1,211 | $12.21 | $14,786 |
| Oct 29, 2026 | Rafael A. Rodriguez Director | Option exercise | +1,776 | $12.21 | $21,685 |
| Oct 29, 2026 | Catherine E. Woteki Director | Option exercise | +1,776 | $12.21 | $21,685 |
| Oct 29, 2026 | Hastings Gregory S Officer (VP, Animal Health) | Shares withheld for tax | −337 | $12.21 | $4,115 |
| Oct 14, 2026 | Hastings Gregory S Officer (VP, Animal Health) | Option exercise | +287 | $12.00 | $3,444 |
| Oct 14, 2026 | Hastings Gregory S Officer (VP, Animal Health) | Shares withheld for tax | −80 | $12.00 | $960 |
| Oct 9, 2026 | Mikheal Nassif Director, Officer (CEO) | Open-market purchase | +505 | $11.95 | $6,035 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Neogen Corporation
Who is the CEO of Neogen Corporation?
Mikheal Nassif has been Neogen Corporation's CEO since August 2025.
How many directors are on Neogen Corporation's board?
Neogen Corporation's board has 13 directors: Aashima Gupta, Andrea F. Wainer, Avi Pelossof, Catherine E. Woteki, James C. Borel, James P. Tobin, Jeffrey D. Capello, John Edward Adent, Mikheal Nassif, Rafael A. Rodriguez and 3 others.
Are Neogen Corporation insiders buying or selling shares?
Over the last 12 months, Neogen Corporation insiders bought $12,421 of shares in 6 purchases and sold $114,676 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="neogen-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.